Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00014651 · ClinicalTrials.gov registry record · Phase 3
Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection
A Phase 3 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 3
- Development phase
NCT00014651: Clinical Trial Phase 3 study, sponsored by Mayo Clinic.
NCT00014651 is a Phase 3 study that was terminated before completion, run by Mayo Clinic. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00014651, a Phase 3 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Drugs such as vapreotide may prevent complications following pancreatic resection. It is not yet known if vapreotide is more effective than no further therapy in preventing side effects of pancreatic resection. PURPOSE: This randomized phase III trial is studying vapreotide to see how well it works compared to a placebo in preventing complications in patients undergoing surgery for pancreatic cancer.
Interventions
- PROCEDURE conventional surgery
- DRUG vapreotide
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-03 |
| Est. Completion | 2002-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00014651
The ClinicalTrials.gov registry entry for NCT00014651 describes a study currently listed as terminated, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which conventional surgery is the first listed.
NCT00014651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00014651 about?
NCT00014651 is a clinical study titled "Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection". RATIONALE: Drugs such as vapreotide may prevent complications following pancreatic resection. It is not yet known if vapreotide is more effective than no further therapy in preventing side effects of pancreatic resection. PURPOSE: This randomized phase III trial is studying vapreotide to see how we...
What is the current status of trial NCT00014651?
This trial is currently terminated. It is a Phase 3 study. The study started on 2001-03. Estimated completion is 2002-04.
What interventions are being tested in trial NCT00014651?
The interventions under investigation include: conventional surgery (PROCEDURE), vapreotide (DRUG).
Who is sponsoring clinical trial NCT00014651?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.